ARCHIVES

House, Senate Must Resolve Major Differences In Authorization Bills

This article is from The Cancer Letter archive.

Vol. 06 No. 36 | September 12, 1980

Download PDF Visit The Full Archive

Related Articles

DCT Programs Status Reported to Board

July 5, 1985

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Obey Accuses Industry Of Blocking Control Of Carcinogens

November 10, 1978

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995